Bristol Myers Squibb Italia, for the fourth consecutive year, is among the top ten companies where work is best in Italy according to the “Best Workplaces Italia 2024” ranking, drawn up by Great Place to Work. The awarded organisations, divided into four dimensional categories, represent the excellence of working environments in Italy from the point of view of corporate culture and organizational well-being. The study combines listening to collaborators with the analysis of company personnel policies; 379 companies were analysed, listening to the opinions of over 219,000 people regarding their working environment.
A lesson in happiness: strategies for seeing life ‘in pink’ by Deborah Ameri 20 March 2024
Measures for employees
Bms Italia, present in our territory for 70 years, participates in the category of medium-large companies: it has around 400 employees, of which 60% are women and 28% millennials. “At BMS we promote a stimulating and engaging work experience, in which every colleague is inspired and motivated to pursue our mission towards patients – explains Fedora Gasperini, Head of HR, Bristol Myers Squibb Italy -. To promote career prospects, we have adopted a culture of continuous learning. We make use of programs so that everyone can benefit from development opportunities and strengthen their skills, gaining diversified experiences. The training is integrated with coaching courses, on-the-job training and initiatives that encourage people to experiment. Wellbeing is also a priority theme, which is why, through our Living Life Better program, we offer dedicated solutions that can meet the different needs of colleagues in areas ranging from physical and mental health, to financial well-being, to work-life balance. Furthermore, at Bristol Myers Squibb we promote a culture based on the values of Inclusion and Diversity, we have various active internal groups that work synergistically on the issues of gender equity, inter-generational contamination and rights of the LGBTQ+ community. Our commitment is to create a favorable environment that allows everyone to develop and express their potential.”
Are we sure that artificial intelligence can replace creativity? by Giuseppe Lavenia 14 March 2024
From research to people
The company’s pipeline is broad and diverse, with more than 45 molecules in various stages of clinical development, across more than 40 diseases in oncology, hematology, cardiovascular and immunology. Recently, the commitment to research is also expanding into new therapeutic areas such as neuroscience. “We have a history of scientific excellence, focused on the research and development of cutting-edge therapies, which has allowed us to achieve important milestones and develop medicines with a significant impact on serious diseases – says Regina Vasiliou, Vice President, General Manager Bristol Myers Squibb Italy -. We are very proud of the result obtained, which once again underlines the continuous commitment to our employees. This important recognition is the reflection of a solid corporate culture, based on shared values that guide our decisions, transparency and mutual trust; it is the result of an environment open to everyone’s contribution, in which ideas are listened to and valued and in which success is shared”.